Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round
26-Feb-2015 -
Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures, the company's founding investor, will also participate. This first funding will help Prexton Therapeutics to develop novel small molecules ...
Parkinson's disease
Series A financing